CVS CVS Health
NYSE · SEC CIK 64803 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $323.70M 2 sales by 2 insiders
- Filings on record
- 285 since 2021-08-05, latest 2026-06-29 15:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBBINS LARRY | Dir | — | $317.47M |
| Mandadi Tilak | EVP, Chief Exp, Tech Off | — | $6.23M |
| Shah Prem S | EVP, Group Pres | — | — |
| Newman Brian | EVP, CFO | — | — |
| Clark James David | SVP, Cont, Chief Acct Off | — | — |
| Balser Jeffrey R. | Dir | — | — |
| Compton-Phillips Amy | EVP, Chief Medical Off | — | — |
| Shulman Douglas H. | Dir | — | — |
| CAPOZZI HEIDI B | EVP, CHRO | — | — |
| Khichi Samrat S. | EVP, GC, CPO | — | — |
Transactions 264
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-13 | 2022-05-11 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $97.99 | +1,282 | 27.5K | +5% | +$125.6K | |
| 2022-05-13 | 2022-05-11 | CVS | Finucane Anne A. | Dir | A - Grant | $97.99 | +1,384 | 5,892 | +31% | +$135.6K | |
| 2022-05-13 | 2022-05-11 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $97.99 | +1,409 | 1,409 | New | +$138.1K | |
| 2022-05-13 | 2022-05-11 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $97.99 | +1,358 | 24.8K | +6% | +$133.1K | |
| D | 2022-05-13 | 2022-05-11 | CVS | LUDWIG EDWARD J | Dir | A - Grant | $97.99 | +165 | 18.5K | +0.9% | +$16.2K |
| 2022-05-13 | 2022-05-11 | CVS | DORMAN DAVID W | Dir | A - Grant | $97.99 | +51 | 109.9K | +0.0% | +$4,997 | |
| 2022-05-13 | 2022-05-11 | CVS | WHITE TONY L | Dir | A - Grant | $97.99 | +38 | 37.9K | +0.1% | +$3,724 | |
| DM | 2022-04-12 | 2022-04-08 | CVS | Shah Prem S | EVP, Co-Pres of Retail | M - OptEx | $62.37 | +13.8K | 50.7K | +38% | +$862.1K |
| DM | 2022-04-12 | 2022-04-08 | CVS | Shah Prem S | EVP, Co-Pres of Retail | S - Sale+OE | $105.00 | -17.0K | 46.6K | -27% | -$1.78M |
| DM | 2022-04-06 | 2022-04-04+ | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | S - Sale+OE | $100.12 | -61.3K | 50.1K | -55% | -$6.14M |
| DM | 2022-04-06 | 2022-04-04 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | M - OptEx | $56.79 | +43.3K | 66.3K | +189% | +$2.46M |
| D | 2022-04-05 | 2022-04-01 | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | F - Tax | $101.09 | -38.1K | 109.2K | -26% | -$3.85M |
| DM | 2022-04-05 | 2022-04-01 | CVS | Shah Prem S | EVP, Co-Pres of Retail | F - Tax | $101.09 | -22.5K | 40.3K | -36% | -$2.27M |
| DM | 2022-04-05 | 2022-04-01+ | CVS | Moriarty Thomas M | EVP, GC | F - Tax | $101.09 | -109.4K | 735.3K | -13% | -$11.06M |
| D | 2022-04-05 | 2022-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $101.09 | -116.9K | 210.1K | -36% | -$11.82M |
| D | 2022-04-05 | 2022-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $101.09 | +3,214 | 12.8K | +33% | +$324.9K |
| DM | 2022-04-05 | 2022-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $101.09 | -6,637 | 29.1K | -19% | -$670.9K |
| M | 2022-04-05 | 2022-04-01+ | CVS | Brennan Troyen A | EVP, Chief Medical Off | F - Tax | $101.09 | -80.1K | 234.9K | -25% | -$8.10M |
| DM | 2022-04-05 | 2022-04-01 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | F - Tax | $101.09 | -17.4K | 50.1K | -26% | -$1.76M |
| D | 2022-03-31 | 2022-03-30 | CVS | Shah Prem S | EVP, Co-Pres of Retail | M - OptEx | $102.26 | +5,346 | 64.4K | +9% | +$546.7K |
| D | 2022-03-31 | 2022-03-30 | CVS | Shah Prem S | EVP, Co-Pres of Retail | S - Sale+OE | $104.70 | -5,346 | 59.1K | -8% | -$559.7K |
| D | 2022-03-18 | 2022-03-17 | CVS | Shah Prem S | EVP, Co-Pres of Retail | M - OptEx | $104.82 | +2,935 | 62.0K | +5% | +$307.6K |
| DM | 2022-03-18 | 2022-03-17 | CVS | Shah Prem S | EVP, Co-Pres of Retail | S - Sale+OE | $106.65 | -4,624 | 59.1K | -7% | -$493.1K |
| D | 2022-03-17 | 2022-03-15 | CVS | Moriarty Thomas M | EVP, GC | S - Sale+OE | $105.00 | -51.4K | 836.8K | -6% | -$5.39M |
| D | 2022-03-17 | 2022-03-15 | CVS | Moriarty Thomas M | EVP, GC | M - OptEx | $102.26 | +51.4K | 888.1K | +6% | +$5.25M |
| M | 2022-03-01 | 2022-02-28 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $103.65 | -436 | 26.7K | -2% | -$45.2K |
| 2022-03-01 | 2022-02-26 | CVS | PELUSO MICHELLE A | EVP, Co-Pres of Retail | F - Tax | $104.30 | -12.6K | 14.9K | -46% | -$1.32M | |
| 2022-03-01 | 2022-02-26 | CVS | Havanec Laurie P. | EVP, CHRO | F - Tax | $104.30 | -5,233 | 9,754 | -35% | -$545.8K | |
| M | 2022-03-01 | 2022-02-26+ | CVS | Shah Prem S | EVP, Co-Pres of Retail | F - Tax | $104.05 | -367 | 59.4K | -0.6% | -$38.2K |
| 2022-02-23 | 2022-02-21 | CVS | Brennan Troyen A | EVP, Chief Medical Off | A - Grant | $0.00 | +171.9K | 312.8K | +122% | $0 | |
| M | 2022-02-23 | 2022-02-21 | CVS | Moriarty Thomas M | EVP, GC | A - Grant | $0.00 | +787.5K | 621.8K | New | $0 |
| 2022-02-23 | 2022-02-21 | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | A - Grant | $0.00 | +86.0K | 147.3K | +140% | $0 | |
| 2022-02-23 | 2022-02-21 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | A - Grant | $0.00 | +34.4K | 57.7K | +147% | $0 | |
| 2022-02-23 | 2022-02-21 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $0.00 | +8,595 | 26.1K | +49% | $0 | |
| 2022-02-23 | 2022-02-21 | CVS | Shah Prem S | EVP, Co-Pres of Retail | A - Grant | $0.00 | +47.6K | 59.6K | +398% | $0 | |
| 2022-02-23 | 2022-02-21 | CVS | Roberts Jonathan C | EVP, COO | A - Grant | $0.00 | +322.4K | 426.0K | +311% | $0 | |
| 2022-02-23 | 2022-02-21 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $0.00 | +257.9K | 327.0K | +373% | $0 | |
| 2022-02-11 | 2022-02-10 | CVS | LUDWIG EDWARD J | Dir | P - Purchase | $105.90 | +1,000 | 18.3K | +6% | +$105.9K | |
| D | 2022-02-04 | 2022-02-03 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $102.26 | +47.9K | 186.2K | +35% | +$4.90M |
| D | 2022-02-04 | 2022-02-03 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $110.00 | -47.9K | 138.2K | -26% | -$5.27M |
| D | 2022-02-02 | 2022-02-01 | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | M - OptEx | $102.26 | +21.4K | 82.7K | +35% | +$2.19M |
| D | 2022-02-02 | 2022-02-01 | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | S - Sale+OE | $106.50 | -21.4K | 61.3K | -26% | -$2.28M |
| D | 2022-02-01 | 2022-01-28 | CVS | Clark James David | SVP, Cont, Chief Acct Off | S - Sale+OE | $109.00 | -6,059 | 17.5K | -26% | -$660.4K |
| D | 2022-02-01 | 2022-01-28 | CVS | Clark James David | SVP, Cont, Chief Acct Off | M - OptEx | $102.26 | +6,059 | 23.6K | +35% | +$619.6K |
| D | 2022-01-28 | 2022-01-27 | CVS | Roberts Jonathan C | EVP, COO | S - Sale+OE | $107.50 | -68.5K | 107.1K | -39% | -$7.36M |
| D | 2022-01-28 | 2022-01-27 | CVS | Roberts Jonathan C | EVP, COO | M - OptEx | $102.26 | +68.5K | 175.6K | +64% | +$7.00M |
| 2021-12-28 | 2021-12-27 | CVS | Lotvin Alan | EVP, Pres-PharmacyServices | F - Tax | $88.78 | -200 | 5,827 | -3% | -$17.8K | |
| 2021-12-03 | 2021-12-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $88.78 | -68 | 16.9K | -0.4% | -$6,037 | |
| 2021-12-01 | 2021-11-28 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $91.52 | -14.1K | 69.1K | -17% | -$1.29M | |
| 2021-11-19 | 2021-11-17 | CVS | DORMAN DAVID W | Dir | A - Grant | $92.73 | +3,154 | 109.8K | +3% | +$292.5K | |
| 2021-11-19 | 2021-11-17 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $92.73 | +1,253 | 26.2K | +5% | +$116.2K | |
| 2021-11-19 | 2021-11-17 | CVS | WHITE TONY L | Dir | A - Grant | $92.73 | +1,314 | 37.8K | +4% | +$121.8K | |
| 2021-11-19 | 2021-11-17 | CVS | Finucane Anne A. | Dir | A - Grant | $92.73 | +1,314 | 1,314 | New | +$121.8K | |
| 2021-11-19 | 2021-11-17 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $92.73 | +1,334 | 23.4K | +6% | +$123.7K | |
| D | 2021-11-19 | 2021-11-17 | CVS | SCHAPIRO MARY L | Dir | A - Grant | $92.73 | +417 | 7,585 | +6% | +$38.7K |
| 2021-11-19 | 2021-11-17 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $92.73 | +1,253 | 1,253 | New | +$116.2K | |
| D | 2021-11-05 | 2021-11-03 | CVS | Roberts Jonathan C | EVP, COO | M - OptEx | $45.93 | +108.9K | 216.0K | +102% | +$5.00M |
| D | 2021-11-05 | 2021-11-03 | CVS | Roberts Jonathan C | EVP, COO | S - Sale+OE | $95.00 | -108.9K | 107.1K | -50% | -$10.34M |
| D | 2021-11-03 | 2021-11-01 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $58.34 | +28.2K | 166.4K | +20% | +$1.64M |
| D | 2021-11-03 | 2021-11-01 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $90.00 | -28.2K | 138.2K | -17% | -$2.53M |
| D | 2021-10-28 | 2021-10-26 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $54.19 | +80.8K | 221.0K | +58% | +$4.38M |
| DM | 2021-10-28 | 2021-10-26 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $88.00 | -82.8K | 219.0K | -27% | -$7.28M |
| 2021-09-07 | 2021-09-02 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale | $87.00 | -2,625 | 140.2K | -2% | -$228.4K | |
| 2021-08-05 | 2021-08-05 | CVS | LUDWIG EDWARD J | Dir | P - Purchase | $79.55 | +3,000 | 17.3K | +21% | +$238.7K |
Purchase Sale Sale after option exercise All abbreviations